BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17709887)

  • 21. The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus.
    Sigurdsson E; Baekkeskov S
    Curr Top Microbiol Immunol; 1990; 164():143-68. PubMed ID: 2073783
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell responses to islet cell antigens.
    Sønderstrup G; Durinovich-Belló I
    Curr Dir Autoimmun; 2001; 4():239-51. PubMed ID: 11569405
    [No Abstract]   [Full Text] [Related]  

  • 25. T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus.
    Kallan AA; de Vries RR; Roep BO
    APMIS; 1996 Jan; 104(1):3-11. PubMed ID: 8645454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin--a primary autoantigen in type 1 diabetes?
    Wong FS
    Trends Mol Med; 2005 Oct; 11(10):445-8. PubMed ID: 16150642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autoantigens in type-I diabetes].
    Becker F; Federlin K
    Immun Infekt; 1991 Dec; 19(6):167-9. PubMed ID: 1802831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes.
    Nakayama M; Simmons KM; Michels AW
    Curr Diab Rep; 2015 Dec; 15(12):113. PubMed ID: 26458384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells.
    Leon MA; Wemlinger SM; Larson NR; Ruffalo JK; Sestak JO; Middaugh CR; Cambier JC; Berkland C
    Mol Pharm; 2019 Apr; 16(4):1563-1572. PubMed ID: 30681867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse.
    Unanue ER; Ferris ST; Carrero JA
    Immunol Rev; 2016 Jul; 272(1):183-201. PubMed ID: 27319351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus.
    Dotta F; Dionisi S; Viglietta V; Tiberti C; Matteoli MC; Cervoni M; Bizzarri C; Marietti G; Testi M; Multari G; Lucentini L; Di Mario U
    Eur J Endocrinol; 1999 Sep; 141(3):272-8. PubMed ID: 10474125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin as an autoantigen in NOD/human diabetes.
    Zhang L; Nakayama M; Eisenbarth GS
    Curr Opin Immunol; 2008 Feb; 20(1):111-8. PubMed ID: 18178393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human islet T cells are highly reactive to preproinsulin in type 1 diabetes.
    Anderson AM; Landry LG; Alkanani AA; Pyle L; Powers AC; Atkinson MA; Mathews CE; Roep BO; Michels AW; Nakayama M
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34611019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell epitopes in type 1 diabetes.
    Panagiotopoulos C; Trudeau JD; Tan R
    Curr Diab Rep; 2004 Apr; 4(2):87-94. PubMed ID: 15035967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 38. Strategies for identifying and predicting islet autoantigen T-cell epitopes in insulin-dependent diabetes mellitus.
    Honeyman MC; Brusic V; Harrison LC
    Ann Med; 1997 Oct; 29(5):401-4. PubMed ID: 9453287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes.
    Puertas MC; Carrillo J; Pastor X; Ampudia RM; Planas R; Alba A; Bruno R; Pujol-Borrell R; Estanyol JM; Vives-Pi M; Verdaguer J
    J Immunol; 2007 May; 178(10):6533-9. PubMed ID: 17475883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.